{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "regularMarketChangePercent": 21.951218, "regularMarketPrice": 0.1, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.04, "sharesOutstanding": 81268496, "bookValue": 0.036, "fiftyDayAverage": 0.08023, "fiftyDayAverageChange": 0.019770004, "fiftyDayAverageChangePercent": 0.24641661, "twoHundredDayAverage": 0.1466175, "twoHundredDayAverageChange": -0.0466175, "twoHundredDayAverageChangePercent": -0.31795317, "marketCap": 8126849, "priceToBook": 2.777778, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1618272000000, "priceHint": 4, "marketState": "PRE", "exchange": "ASX", "shortName": "ISLAND PHA FPO", "longName": "Island Pharmaceuticals Limited", "messageBoardId": "finmb_591460339", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketChange": 0.018, "regularMarketTime": 1683784032, "regularMarketDayHigh": 0.12, "regularMarketDayRange": "0.09 - 0.12", "regularMarketDayLow": 0.09, "regularMarketVolume": 289900, "regularMarketPreviousClose": 0.082, "bid": 0.1, "ask": 0.105, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.09, "averageDailyVolume3Month": 40433, "averageDailyVolume10Day": 38987, "fiftyTwoWeekLowChange": 0.030000001, "fiftyTwoWeekLowChangePercent": 0.42857143, "fiftyTwoWeekRange": "0.07 - 0.22", "fiftyTwoWeekHighChange": -0.12, "fiftyTwoWeekHighChangePercent": -0.54545456, "fiftyTwoWeekLow": 0.07, "fiftyTwoWeekHigh": 0.22, "symbol": "ILA.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "697 Burke Road", "address2": "Suite 201", "city": "Camberwell", "state": "VIC", "zip": "3124", "country": "Australia", "phone": "61 3 7036 7675", "website": "https://www.islandpharmaceuticals.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; and research collaboration agreement with Compounds Australia, a drug library containing approximately four and a half thousand molecules that could be searched for drug re-purposing and pipeline development. It also has a cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was founded in 2017 and is based in Camberwell, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul Donald Richard MacLeman BVSc, GAICD, Grad Cert Eng, Grad Dip Tech, M.B.A.", "age": 56, "title": "Exec. Chairman", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 150000, "fmt": "150k", "longFmt": "150,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David Charles Foster", "title": "MD, CEO, Pres & Exec. Director", "fiscalYear": 2022, "totalPay": {"raw": 254167, "fmt": "254.17k", "longFmt": "254,167"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICD", "age": 59, "title": "Company Sec.", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}